Xin Li1, Xiao-Yan Zhang2, Qiu-Ju Wang3, Da-Yong Wang3. 1. Department of Otorhinolaryngology, Beijing Tsinghua Changgung Hospital Beijing 102218, China ; Department of Otorhinolaryngology Head and Neck Surgery, PLA Genteral Hospital Beijing 100853, China. 2. Department of Otorhinolaryngology Head and Neck Surgery, PLA Genteral Hospital Beijing 100853, China ; Department of Allergic Reaction, Qinhuangdao First Hospital Qinhuangdao 066000, China. 3. Department of Otorhinolaryngology Head and Neck Surgery, PLA Genteral Hospital Beijing 100853, China.
Abstract
OBJECTIVE: To investigate the effect of injecting the methylprednisolone in the ear for the sudden deafness and the improvement of speech discrimination test. METHODS: 50 inpatients with a sudden hearing loss were recruited. Inject the methylprednisolone in the subperiosteal of the ear which is 0.5 cm distance to the ear ditch every three days. Methylprednisolone was placed for fifteen days. Simultaneously vasodilation, neurotrophic, thrombolysis and insulin hypoglycemia were administered in all patients. Pure tone test and speech discrimination test were conducted at Days 7 & 14 after intervention. RESULTS: The outcome was as follows: cure (n = 8), efficacy (n = 9), effect (n = 18) and no effect (n = 15) respectively. The overall effective rate of 70%. The improvement of pure tone threshold and speech discrimination had significant statistical difference (P < 0.05). CONCLUSION: The therapy of postaural methylprednisolone injection can decrease pure tone threshold effectively and increased speech discrimination with a sudden hearing loss.
OBJECTIVE: To investigate the effect of injecting the methylprednisolone in the ear for the sudden deafness and the improvement of speech discrimination test. METHODS: 50 inpatients with a sudden hearing loss were recruited. Inject the methylprednisolone in the subperiosteal of the ear which is 0.5 cm distance to the ear ditch every three days. Methylprednisolone was placed for fifteen days. Simultaneously vasodilation, neurotrophic, thrombolysis and insulin hypoglycemia were administered in all patients. Pure tone test and speech discrimination test were conducted at Days 7 & 14 after intervention. RESULTS: The outcome was as follows: cure (n = 8), efficacy (n = 9), effect (n = 18) and no effect (n = 15) respectively. The overall effective rate of 70%. The improvement of pure tone threshold and speech discrimination had significant statistical difference (P < 0.05). CONCLUSION: The therapy of postaural methylprednisolone injection can decrease pure tone threshold effectively and increased speech discrimination with a sudden hearing loss.